Dr. Mohammed Almubarak, MD
Claim this profileWest Virginia University Healthcare
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
13 reported clinical trials
59 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage IV
Stage II
2Non-Small Cell Lung Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Mohammed Almubarak, MD is currently running
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting1 award Phase 211 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Mohammed Almubarak, MD
Clinical Trial Related8 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Mohammed Almubarak, MD has experience with
- Pembrolizumab
- Biospecimen Collection
- Ipatasertib
- Binimetinib
- Paclitaxel
- Palbociclib
Breakdown of trials Mohammed Almubarak, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mohammed Almubarak, MD specialize in?
Mohammed Almubarak, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Mohammed Almubarak, MD currently recruiting for clinical trials?
Yes, Mohammed Almubarak, MD is currently recruiting for 8 clinical trials in Morgantown West Virginia. If you're interested in participating, you should apply.
Are there any treatments that Mohammed Almubarak, MD has studied deeply?
Yes, Mohammed Almubarak, MD has studied treatments such as Pembrolizumab, Biospecimen Collection, Ipatasertib.
What is the best way to schedule an appointment with Mohammed Almubarak, MD?
Apply for one of the trials that Mohammed Almubarak, MD is conducting.
What is the office address of Mohammed Almubarak, MD?
The office of Mohammed Almubarak, MD is located at: West Virginia University Healthcare, Morgantown, West Virginia 26506 United States. This is the address for their practice at the West Virginia University Healthcare.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.